AMAG Pharmaceuticals, Inc. To Present At The Lazard Capital Markets 9th Annual Healthcare Conference

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that Frank Thomas, AMAG’s Chief Operating Officer, will present a company overview and business update at the Lazard Capital Markets 9 th Annual Healthcare Conference on Tuesday, November 13, 2012 at 8:00 am ET in New York, NY.

A live webcast of the presentation will be accessible through the Investors section of the company’s website at Following the conference, the webcast will be archived on the AMAG Pharmaceuticals, Inc. website until December 13, 2012.

About AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia. For additional company information, please visit

Copyright Business Wire 2010

If you liked this article you might like

Biotech Movers: Luminex, Exelixis, AMAG Pharmaceuticals

Biotech Premarket Movers: Pacific Biosciences of California, AMAG, Global Blood Therapeutics

Today's Perilous Reversal Stock: AMAG Pharmaceuticals (AMAG)

Practice Patience With AMAG Pharma

Practice Patience With AMAG Pharma

Allergan Could Buy These Drug Companies Now That the Pfizer Merger Is Scuttled